Low dosage proteases, clotting factors, capillary permeability and cellular viability.
D000284:Administration, Oral; D000818:Animals; D001779:Blood Coagulation Factors / Q000502:physiology*; D001920:Bradykinin / Q000494:pharmacology; D002199:Capillary Permeability / Q000187:drug effects*; D006168:Guinea Pigs; D007273:Injections, Intramuscular; D010206:Papain / Q000494:pharmacology; D010447:Peptide Hydrolases / Q000494:pharmacology*; D011517:Prothrombin Time; D011817:Rabbits; D012867:Skin / Q000187:drug effects; D013300:Streptokinase / Q000494:pharmacology; D014859:Warfarin / Q000494:pharmacology*
D001779:Blood Coagulation Factors; D014859:Warfarin; D010447:Peptide Hydrolases; D013300:Streptokinase; D010206:Papain; D001920:Bradykinin